These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 1717289

  • 1. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity.
    Meyerhans A, Dadaglio G, Vartanian JP, Langlade-Demoyen P, Frank R, Asjö B, Plata F, Wain-Hobson S.
    Eur J Immunol; 1991 Oct; 21(10):2637-40. PubMed ID: 1717289
    [Abstract] [Full Text] [Related]

  • 2. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    Nietfield W, Bauer M, Fevrier M, Maier R, Holzwarth B, Frank R, Maier B, Riviere Y, Meyerhans A.
    J Immunol; 1995 Mar 01; 154(5):2189-97. PubMed ID: 7868892
    [Abstract] [Full Text] [Related]

  • 3. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 4. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA, Klein MR, Geretti AM, Keet RI, Miedema F, van Els CA, Osterhaus AD.
    AIDS; 1993 Jun 01; 7(6):781-6. PubMed ID: 7689847
    [Abstract] [Full Text] [Related]

  • 5. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD.
    J Immunol; 1998 Nov 01; 161(9):4875-81. PubMed ID: 9794421
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM, Friedline R, Poligone B, Pogue-Caley RR, Frelinger JA, Tisch R.
    Clin Immunol; 2001 Oct 01; 101(1):51-8. PubMed ID: 11580226
    [Abstract] [Full Text] [Related]

  • 7. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H, Miwa K, Shiga H, Moore YI, Oka S, Iwamoto A, Kaneko Y, Takiguchi M.
    J Immunol; 1997 May 15; 158(10):5026-34. PubMed ID: 9144523
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.
    Chen ZW, Shen L, Miller MD, Ghim SH, Hughes AL, Letvin NL.
    J Immunol; 1992 Dec 15; 149(12):4060-6. PubMed ID: 1460291
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope.
    Gotch F, McAdam SN, Allsopp CE, Gallimore A, Elvin J, Kieny MP, Hill AV, McMichael AJ, Whittle HC.
    J Immunol; 1993 Sep 15; 151(6):3361-9. PubMed ID: 7690804
    [Abstract] [Full Text] [Related]

  • 10. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
    Sewell AK, Harcourt GC, Goulder PJ, Price DA, Phillips RE.
    Eur J Immunol; 1997 Sep 15; 27(9):2323-9. PubMed ID: 9341776
    [Abstract] [Full Text] [Related]

  • 11. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
    Hadida F, Haas G, Zimmermann N, Hosmalin A, Spohn R, Samri A, Jung G, Debre P, Autran B.
    J Immunol; 1995 Apr 15; 154(8):4174-86. PubMed ID: 7535824
    [Abstract] [Full Text] [Related]

  • 12. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, Le Gall S, John M, Mothe BR, Lee PK, Kalife ET, Cohen DE, Freedberg KA, Strick DA, Johnston MN, Sette A, Rosenberg ES, Mallal SA, Goulder PJ, Brander C, Walker BD.
    J Virol; 2004 Jul 15; 78(13):7069-78. PubMed ID: 15194783
    [Abstract] [Full Text] [Related]

  • 13. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
    Jassoy C, Johnson RP, Navia BA, Worth J, Walker BD.
    J Immunol; 1992 Nov 01; 149(9):3113-9. PubMed ID: 1383338
    [Abstract] [Full Text] [Related]

  • 14. Antigenic oscillations and shifting immunodominance in HIV-1 infections.
    Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Köppe B, Sigmund K, Bangham CR.
    Nature; 1995 Jun 15; 375(6532):606-11. PubMed ID: 7791879
    [Abstract] [Full Text] [Related]

  • 15. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T.
    Viral Immunol; 2005 Jun 15; 18(4):627-36. PubMed ID: 16359229
    [Abstract] [Full Text] [Related]

  • 16. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    Altfeld M, Allen TM, Kalife ET, Frahm N, Addo MM, Mothe BR, Rathod A, Reyor LL, Harlow J, Yu XG, Perkins B, Robinson LK, Sidney J, Alter G, Lichterfeld M, Sette A, Rosenberg ES, Goulder PJ, Brander C, Walker BD.
    J Virol; 2005 Apr 15; 79(8):5000-5. PubMed ID: 15795285
    [Abstract] [Full Text] [Related]

  • 17. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR, Bhonge LS, Lakhashe SK, Shankarkumar U, Sane SS, Kulkarni SS, Mahajan BA, Paranjape RS.
    J Infect Dis; 2005 Sep 01; 192(5):749-59. PubMed ID: 16088824
    [Abstract] [Full Text] [Related]

  • 18. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands.
    Cornelissen M, Hoogland FM, Back NK, Jurriaans S, Zorgdrager F, Bakker M, Brinkman K, Prins M, van der Kuyl AC.
    AIDS; 2009 Jul 31; 23(12):1495-500. PubMed ID: 19487902
    [Abstract] [Full Text] [Related]

  • 19. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
    Klenerman P, Meier UC, Phillips RE, McMichael AJ.
    Eur J Immunol; 1995 Jul 31; 25(7):1927-31. PubMed ID: 7542596
    [Abstract] [Full Text] [Related]

  • 20. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses.
    Bowness P, Moss PA, Rowland-Jones S, Bell JI, McMichael AJ.
    Eur J Immunol; 1993 Jul 31; 23(7):1417-21. PubMed ID: 8391985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.